ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

DCE Board Delays Decision On New Collaborative Groups In Chemoprevention

November 30, 1984

New ESA Label Maintains 12 g/dL

November 9, 2007

In Brief: Emory Univ. Receives $295 Million Endowment; Winship Cancer Center To Get Half of Income

August 16, 1996

Sentinel Lymph Node Excision Has No Impact on Survival

August 26, 2011

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

NIH Panel Finds Older GI Imaging Tool Still Useful In Treating Pancreatic Diseases

February 22, 2002